MEET THE EXPERTS

Methods and strategies to address challenges in contamination control for pharmaceutical environments

AM Event | Ecolab
Oct. 9, 2025 | H 09:00 - 15:00
AM Headquarters
Via Isonzo 1/C, Limbiate MB

The day dedicated to those who face the challenges of cleaning and disinfection in contamination-controlled environments every day.

AM | Ecolab: a partnership dedicated to the pharmaceutical industry

Case Study: Contamination control assessment cleaning and disinfection

This presentation explores the principles of Contamination Control Strategy (CCS) in the pharmaceutical industry, with a focus on cleaning and disinfection processes. Key elements such as microbial and particulate contamination and ensuring sterility are covered: a case study related to residue management and material transfer processes in a sterile pharmaceutical production, emphasizing protective measures and effective disinfection techniques.

Assessment and management of disinfectant residues in the cleanroom

Considering the revised version ofEudraLex Annex 1 Volume 4, published in August 2022, residue management has gained more importance, with references in four different sections of the document.

Specifically, under "Disinfection," Section 4.33 states, "Cleaning programs should effectively remove disinfectant residues."

This presentation demonstrates how visual inspection (visual inspection) alone may not be sufficient for proper residue management and introduces an analytical method published by Ecolab for detecting disinfectant residues on a surface and its application for verifying the effectiveness of rinsing techniques.

Workshop: Material Transfer (theoretical and practical session)

A practical demonstration on the importance of using the correct packaging cleaning technique through the proper use of wipes during the material transfer process, respecting class jumps; here, effective methods for removing contamination from packaging are examined.

Addressing the Challenge of Mould in GMP Environments

Fungal and yeast contamination in contamination-controlled environments can pose a significant challenge to drug manufacturing, as it carries the risk of compromising the quality of the finished product and patient safety. Understanding its complexity, including the major strains of interest, is essential to implement effective control measures.

This presentation discusses the morphology of fungi and yeasts, the possible sources of contamination, the risks and challenges they pose, and the need to structure a system of preventive and corrective actions (CAPA plan) that can avoid problems of regulatory noncompliance.

Speakers
  • M. Lipardi (Sales Manager Italy - Ecolab)
  • A. Soldi (Product Manager Contamination Control Solutions - AM)
  • D. Collins (Principal Global Technical Consultant - Ecolab)
  • J. Forbes (Senior Global Technical Consultant Manager - Ecolab)
More information

Participation is free of charge and is subject to preregistration and confirmation by AM, which reserves the right to limit or cancel registrations based on seat availability.

Applications will be accepted on a first-come, first-served basis, subject to availability.

The reports will be in English.

© Copyright1990-2026 – AM Instruments Srl – VAT number 02196040964 – Privacy PolicyCookie Policy